Laboratory Oncology Unit, Department of Medical Oncology, Dr. B.R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
Leuk Res. 2011 Jul;35(7):874-8. doi: 10.1016/j.leukres.2010.11.010. Epub 2010 Dec 10.
Increases in regulatory T-cells have been demonstrated in hematological malignancies but conflicting results have been reported in multiple myeloma (MM). In this study, we report a decrease in frequency of regulatory T-cells as well as reduced expression of FoxP3 in untreated MM patients which increased significantly after treatment. Regulatory T-cells of MM patients exhibited immunosuppressive activity in an in vitro assay. Reduced regulatory T-cells in untreated MM patients which increased after treatment with thalidomide, suggests the analysis of treated and untreated patients as a single cohort as cause of conflicting results in earlier studies on regulatory T-cells in MM.
在血液系统恶性肿瘤中已经证实调节性 T 细胞增加,但在多发性骨髓瘤(MM)中已有多项研究报道结果相矛盾。在这项研究中,我们报告了未经治疗的 MM 患者调节性 T 细胞频率降低,FoxP3 表达减少,治疗后显著增加。MM 患者的调节性 T 细胞在体外试验中具有免疫抑制活性。未经治疗的 MM 患者的调节性 T 细胞减少,在用沙利度胺治疗后增加,这表明将治疗和未治疗的患者作为单一队列进行分析是导致早期 MM 中调节性 T 细胞研究结果相矛盾的原因。